| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 07/01/2023 | KINETA, INC./DE | PTI | Grant | Stock Option (Right to Buy) | 20k | $2.58 | $51.6k | | 07/01/2023 |
| 06/06/2023 | Acumen Pharmaceuticals, Inc. | | Grant | Stock Option (right to buy) | 25k | $5.20 | $130k | | 06/06/2023 |
| 01/10/2023 | Jounce Therapeutics, Inc. | JNCE | Sale | Common Stock | 7.8k | $1.12 | $8.7k | | 01/09/2023 |
| 01/09/2023 | Jounce Therapeutics, Inc. | JNCE | Sale | Common Stock | 6.3k | $1.10 | $6.9k | | 01/09/2023 |
| 06/15/2022 | Acumen Pharmaceuticals, Inc. | | Grant | Stock Option (right to buy) | 25k | $3.59 | $89.8k | | 06/15/2022 |
| 04/01/2022 | Acumen Pharmaceuticals, Inc. | | Grant | Stock Option Grant (right to buy) | 50k | $4.01 | $200.5k | | 04/01/2022 |
| 02/01/2022 | Jounce Therapeutics, Inc. | JNCE | Grant | Common Stock | 27.5k | $0.00 | $0 | | 02/01/2022 |
| 02/01/2022 | Jounce Therapeutics, Inc. | JNCE | Grant | Stock Option (Right to Buy) | 55k | $7.56 | $415.8k | | 02/01/2022 |
| 01/10/2022 | Jounce Therapeutics, Inc. | JNCE | Sale | Common Stock | 8.2k | $6.65 | $54.7k | | 01/07/2022 |
| 01/07/2022 | Jounce Therapeutics, Inc. | JNCE | Sale | Common Stock | 4.6k | $7.30 | $33.5k | | 01/07/2022 |
| 06/02/2021 | KINETA, INC./DE | PTI | Grant | Stock Option (Right to Buy) | 14.8k | $15.26 | $225.8k | | 06/02/2021 |
| 02/01/2021 | Jounce Therapeutics, Inc. | JNCE | Grant | Stock Option (Right to Buy) | 44.5k | $11.89 | $529.1k | | 02/01/2021 |
| 02/01/2021 | Jounce Therapeutics, Inc. | JNCE | Grant | Common Stock | 22.2k | $0.00 | $0 | | 02/01/2021 |
| 01/21/2021 | Jounce Therapeutics, Inc. | JNCE | Sale | Common Stock | 3.8k | $12.00 | $45.6k | | 01/20/2021 |
| 01/21/2021 | Jounce Therapeutics, Inc. | JNCE | Exercise | Stock Option (Right to Buy) | 3.8k | $2.36 | $9k | | 01/20/2021 |
| 01/20/2021 | Jounce Therapeutics, Inc. | JNCE | Sale | Common Stock | 10k | $10.03 | $100.3k | | 01/20/2021 |
| 01/20/2021 | Jounce Therapeutics, Inc. | JNCE | Sale | Common Stock | 16.2k | $12.03 | $194.9k | | 01/20/2021 |
| 01/20/2021 | Jounce Therapeutics, Inc. | JNCE | Exercise | Stock Option (Right to Buy) | 3k | $0.48 | $1.4k | | 01/20/2021 |
| 01/20/2021 | Jounce Therapeutics, Inc. | JNCE | Exercise | Stock Option (Right to Buy) | 6.8k | $0.74 | $5k | | 01/20/2021 |
| 01/20/2021 | Jounce Therapeutics, Inc. | JNCE | Exercise | Stock Option (Right to Buy) | 3.7k | $2.36 | $8.8k | | 01/20/2021 |
| 01/08/2021 | Jounce Therapeutics, Inc. | JNCE | Sale | Common Stock | 3.1k | $7.00 | $21.9k | | 01/07/2021 |
| 01/07/2021 | Jounce Therapeutics, Inc. | JNCE | Sale | Common Stock | 2.7k | $6.76 | $18.2k | | 01/07/2021 |
| 09/01/2020 | Jounce Therapeutics, Inc. | JNCE | Sale | Common Stock | 7.2k | $8.06 | $58k | | 09/01/2020 |
| 08/18/2020 | Jounce Therapeutics, Inc. | JNCE | Sale | Common Stock | 744 | $4.71 | $3.5k | | 08/14/2020 |
| 08/17/2020 | Jounce Therapeutics, Inc. | JNCE | Sale | Common Stock | 454 | $4.86 | $2.2k | | 08/14/2020 |
| 08/14/2020 | Jounce Therapeutics, Inc. | JNCE | Sale | Common Stock | 984 | $4.64 | $4.6k | | 08/14/2020 |
| 06/29/2020 | KINETA, INC./DE | PTI | Grant | Stock Option (Right to Buy) | 17.4k | $1.39 | $24.2k | | 06/29/2020 |
| 02/03/2020 | Jounce Therapeutics, Inc. | JNCE | Grant | Common Stock | 53.4k | $6.55 | $349.8k | | 02/03/2020 |
| 02/03/2020 | Jounce Therapeutics, Inc. | JNCE | Grant | Common Stock | 26.7k | $0.00 | $0 | | 02/03/2020 |
| 01/07/2020 | Jounce Therapeutics, Inc. | JNCE | Sale | Common Stock | 2.6k | $7.78 | $20.4k | | 01/07/2020 |
| 08/16/2019 | Jounce Therapeutics, Inc. | JNCE | Sale | Common Stock | 1k | $3.92 | $4k | | 08/14/2019 |
| 08/15/2019 | Jounce Therapeutics, Inc. | JNCE | Sale | Common Stock | 648 | $4.00 | $2.6k | | 08/14/2019 |
| 08/14/2019 | Jounce Therapeutics, Inc. | JNCE | Sale | Common Stock | 670 | $4.10 | $2.7k | | 08/14/2019 |
| 02/01/2019 | Jounce Therapeutics, Inc. | JNCE | Grant | Common Stock | 22.2k | $0.00 | $0 | | 02/01/2019 |
| 02/01/2019 | Jounce Therapeutics, Inc. | JNCE | Grant | Stock Option (Right to Buy) | 44.5k | $4.40 | $195.8k | | 02/01/2019 |
|